We were glad to take part in BioHK2026 at the Hong Kong Convention and Exhibition Centre last week, and to meet many friends and professionals from the biotech, healthcare and life sciences sectors.

Our Yolanda Wang moderated the Patent Session panel, "Protect & Resolve: The Biotech IP Playbook for Going Global," on September 12. The discussion covered practical points for biotech companies expanding internationally, including IP planning, risk management and dispute resolution.

Many thanks to the organizers, fellow panelists and everyone who joined the discussion. It was a pleasure to be part of the programme.

As biotech companies continue to look beyond their home markets, early and practical IP strategy will remain an important part of business growth.

Our Past Events

Recommended Insights

How Smart is a "Skilled Person in the Art"?

11 April 2022
Let’s start with a riddle: can you name a person who has read every book, every journal, conducted every known experiment, and is knowledgeable about every single patent prosecution / litigation in the world? The answer? A “skilled person in the art.” This person is also known as a “person having ordinary skill in the […]

The Secret Prior Art Trap: A Case Study on Conflicting Applications in China

13 November 2025
In patent prosecution, the concept of a "conflicting application" or “secret prior art” plays a critical role in determining the patentability of an invention. This article explores the framework for assessing conflicting applications under Chinese patent law, with a comparative perspective on the approaches adopted in the United States. Case Background: The Image Encoding Dispute […]

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

10 March 2025
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]

Obviousness: can features from different categories of products be combined to invalidate a design patent?

18 September 2025
Introduction “I have a tank, I have a gun—boom! Tank gun?” Each year the CNIPA releases a list of Top Ten Patent Re-examination and Invalidation Cases. These cases are meant to be guiding cases, showcasing exemplary real-world decisions that clarify certain aspects of the law. Over the next several months we will be highlighting many […]
Top crossarrow-right